Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study.
作者信息
Fernández-de-Las-Peñas César, Torres-Macho Juan, Velasco-Arribas Maria, Arias-Navalón Jose A, Guijarro Carlos, Hernández-Barrera Valentín, Canto-Diez MGabriela
机构信息
Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), Madrid. Spain.
Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, Madrid Spain; Department of Medicine, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
出版信息
J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.04.034. Epub 2021 May 3.
Abstract
摘要
相似文献
1
Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study.哮喘患者中新冠后长期症状的患病率相似：一项病例对照研究。
J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.04.034. Epub 2021 May 3.
2
[Prevalence of asthma in patients hospitalized for pneumonia associated to SARS-CoV-2 infection].[因新型冠状病毒肺炎住院患者中哮喘的患病率]
Rev Alerg Mex. 2023 May 24;70(1):1-7. doi: 10.29262/ram.v70i1.1175.
3
Low prevalence of post-COVID-19 syndrome in patients with asthma.哮喘患者中新冠后综合征的低患病率。
J Infect. 2021 Jun;82(6):276-316. doi: 10.1016/j.jinf.2021.03.023. Epub 2021 Apr 2.
4
Prevalence, Characteristics, and Outcome of Asthmatic Patients With Type 2 Diseases in Hospitalized Patients With COVID-19 in Madrid, Spain.西班牙马德里新冠肺炎住院患者中合并2型疾病的哮喘患者的患病率、特征及结局
J Investig Allergol Clin Immunol. 2020;30(5):382-384. doi: 10.18176/jiaci.0627. Epub 2020 Jun 18.
5
Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease.为何 COVID-19 患者的哮喘发病率较低，这证明了将 EDTA 溶液重新用于预防和治疗 COVID-19 疾病是合理的。
Med Hypotheses. 2020 Nov;144:110027. doi: 10.1016/j.mehy.2020.110027. Epub 2020 Jun 26.
6
Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19.新型冠状病毒肺炎患者中哮喘表型、相关共病和长期症状。
Allergy. 2022 Jan;77(1):173-185. doi: 10.1111/all.14972. Epub 2021 Jun 19.
7
Asthma in COVID-19 patients: An extra chain fitting around the neck?新冠病毒感染患者的哮喘：脖子上的又一条锁链？
Respir Med. 2020 Dec;175:106205. doi: 10.1016/j.rmed.2020.106205. Epub 2020 Nov 11.
8
Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic.2020年疫情期间一项横断面研究：SARS-CoV-2逆转录实时聚合酶链反应（rtRT-PCR）检测呈阳性的墨西哥儿童和成人中哮喘的低患病率
Allergol Immunopathol (Madr). 2021 May 1;49(3):1-7. doi: 10.15586/aei.v49i3.7. eCollection 2021.
9
Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization.RT-PCR 检测的、无需住院的 SARS-CoV-2 感染患者中的哮喘患病率。
Respir Med. 2020 Sep;171:106084. doi: 10.1016/j.rmed.2020.106084. Epub 2020 Jul 4.
10
Asthma in patients with coronavirus disease 2019: A systematic review and meta-analysis.2019 冠状病毒病患者的哮喘：系统评价和荟萃分析。
Ann Allergy Asthma Immunol. 2021 May;126(5):524-534. doi: 10.1016/j.anai.2021.02.013. Epub 2021 Feb 18.
引用本文的文献
1
COVID-19 Pediatric Follow-Up: Respiratory Long COVID-Associated Comorbidities and Lung Ultrasound Alterations in a Cohort of Italian Children.新冠病毒病（COVID-19）儿童随访：一组意大利儿童中与新冠后长期呼吸相关的合并症及肺部超声改变
Children (Basel). 2024 Jan 27;11(2):166. doi: 10.3390/children11020166.
2
SARS-CoV-2 post-acute sequelae in previously hospitalised patients: systematic literature review and meta-analysis.SARS-CoV-2 后急性后遗症在既往住院患者中的研究：系统文献回顾和荟萃分析。
Eur Respir Rev. 2023 Jul 12;32(169). doi: 10.1183/16000617.0254-2022. Print 2023 Sep 30.
3
Role of Wearable Sensing Technology to Manage Long COVID.可穿戴传感技术在管理长新冠中的作用。
Biosensors (Basel). 2022 Dec 31;13(1):62. doi: 10.3390/bios13010062.
4
Post-Acute COVID-19 Respiratory Symptoms in Patients With Asthma: An Electronic Health Records-Based Study.哮喘患者 COVID-19 后呼吸道症状：一项基于电子健康记录的研究。
J Allergy Clin Immunol Pract. 2023 Mar;11(3):825-835.e3. doi: 10.1016/j.jaip.2022.12.003. Epub 2022 Dec 22.
5
Long COVID outcomes in an asthmatic cohort and its implications for asthma control.哮喘队列中的长期新冠病毒感染结局及其对哮喘控制的影响。
Respir Med. 2023 Feb;207:107092. doi: 10.1016/j.rmed.2022.107092. Epub 2022 Dec 16.
6
Long COVID: The latest manifestations, mechanisms, and potential therapeutic interventions.长新冠：最新表现、机制及潜在治疗干预措施
MedComm (2020). 2022 Dec 8;3(4):e196. doi: 10.1002/mco2.196. eCollection 2022 Dec.
7
Forthcoming complications in recovered COVID-19 patients with COPD and asthma; possible therapeutic opportunities.康复的 COVID-19 合并 COPD 和哮喘患者的即将出现的并发症；可能的治疗机会。
Cell Commun Signal. 2022 Nov 1;20(1):173. doi: 10.1186/s12964-022-00982-5.
8
A New Look on Long-COVID Effects: The Functional Brain Fog Syndrome.新冠长期症状的新视角：功能性脑雾综合征
J Clin Med. 2022 Sep 21;11(19):5529. doi: 10.3390/jcm11195529.
9
Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical co-morbidities in previously hospitalized COVID-19 survivors.聚类分析揭示了与长期 COVID 后症状、住院时 COVID-19 症状和先前住院 COVID-19 幸存者先前合并症相关的不同特征。
Infection. 2023 Feb;51(1):61-69. doi: 10.1007/s15010-022-01822-x. Epub 2022 Apr 22.
10
Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study.女性性别是与新冠后长期相关症状相关的风险因素，但与新冠病毒病症状无关：LONG-COVID-EXP-CM多中心研究
J Clin Med. 2022 Jan 14;11(2):413. doi: 10.3390/jcm11020413.
本文引用的文献
1
Low prevalence of post-COVID-19 syndrome in patients with asthma.哮喘患者中新冠后综合征的低患病率。
J Infect. 2021 Jun;82(6):276-316. doi: 10.1016/j.jinf.2021.03.023. Epub 2021 Apr 2.
2
Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study.预先存在的呼吸道疾病及其治疗与 COVID-19 重症之间的关联：一项人群队列研究。
Lancet Respir Med. 2021 Aug;9(8):909-923. doi: 10.1016/S2213-2600(21)00095-3. Epub 2021 Apr 1.
3
Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis.哮喘与 COVID-19 感染、住院、入住 ICU 和死亡风险：系统评价和荟萃分析。
J Asthma. 2022 May;59(5):866-879. doi: 10.1080/02770903.2021.1888116. Epub 2021 Apr 1.
4
Asthma and COVID-19; different entities, same outcome: a meta-analysis of 107,983 patients.哮喘与2019冠状病毒病；不同的疾病，相同的结局：对107983例患者的荟萃分析
J Asthma. 2022 May;59(5):851-858. doi: 10.1080/02770903.2021.1881970. Epub 2021 Feb 22.
5
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study.新冠病毒感染后综合征。发生率和危险因素：一项地中海队列研究。
J Infect. 2021 Mar;82(3):378-383. doi: 10.1016/j.jinf.2021.01.004. Epub 2021 Jan 12.
6
Long covid: How to define it and how to manage it.长期新冠：如何定义及如何应对。
BMJ. 2020 Sep 7;370:m3489. doi: 10.1136/bmj.m3489.
7
Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19.COVID-19 住院后出院后持续存在的症状和与健康相关的生活质量。
J Infect. 2020 Dec;81(6):e4-e6. doi: 10.1016/j.jinf.2020.08.029. Epub 2020 Aug 25.
8
Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis.新冠病毒感染患者的动脉高血压与死亡风险：系统评价与荟萃分析
J Infect. 2020 Jul;81(1):e84-e86. doi: 10.1016/j.jinf.2020.03.059. Epub 2020 Apr 11.
9
Telephone versus internet administration of self-report measures of social anxiety, depressive symptoms, and insomnia: psychometric evaluation of a method to reduce the impact of missing data.电话与互联网方式进行社交焦虑、抑郁症状及失眠的自我报告测量：减少缺失数据影响方法的心理测量学评估
J Med Internet Res. 2013 Oct 18;15(10):e229. doi: 10.2196/jmir.2818.
Zotero 插件